ORCL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ORCL is not a good buy right now for an impatient investor. The stock remains in a clear downtrend (bearish moving-average stack and worsening MACD), and there is no Intellectia buy signal to override that. While the stock is oversold and sitting near support (creating bounce potential), the dominant setup still favors waiting for a trend reversal (e.g., reclaiming the 178.5 pivot / holding above it) rather than buying immediately.
Price/Trend: Pre-market ~167.2 (-1.17%) with the broader market also risk-off (S&P 500 -0.44%). Trend structure is bearish (SMA_200 > SMA_20 > SMA_5), implying rallies are still likely to be sold. Momentum: MACD histogram at -1.274 and negatively expanding indicates downside momentum is strengthening, not stabilizing. RSI: RSI_6 ~26.3 (oversold/washed-out). This supports the case for a short-term bounce, but oversold can persist in strong downtrends. Levels: Pivot (key reclaim level) 178.484. Nearby support S1 165.691 (price is very close—critical). If S1 breaks, next support S2 ~157.788. Resistance levels to clear for a real reversal: 178.484 then 191.278. Pattern-based odds: Similar-pattern model suggests modest upside probabilities (next day +1.12%, next week +0.79%, next month +3.46%), which is supportive of a bounce but not strong enough to overrule the prevailing downtrend.
Intellectia Proprietary Trading Signals
showed strong YoY growth in revenue (+14.22%) and especially EPS (+90.91%) and net income (+94.70%), which can help support rebounds if execution concerns ease.
Downtrend and weak tape: Technicals are still decisively bearish; price is near a key support (165.7). A breakdown can accelerate selling.
Capex/funding/credit overhang: Multiple notes emphasize sharply higher capex, free cash flow pressure, and funding/leverage concerns. Morgan Stanley explicitly questions the path to EPS targets under the buildout.
OpenAI-related uncertainty: Prior concerns around timing/capacity delivery and tenant concentration continue to be a sentiment risk even when management disputes specific claims.
Margins: Gross margin fell to 64% (down ~5.74% YoY), suggesting profitability mix/cost pressure during the infrastructure ramp.
No supportive “smart money” tilt: Hedge funds and insiders are reported as neutral (no significant recent trend), so there’s no strong reinforcement from positioning data.
Latest reported quarter: 2026/Q2. Growth: Revenue increased to $16.058B (+14.22% YoY), indicating the core top-line trend is still healthy. Profitability: Net income rose to $6.135B (+94.70% YoY) and EPS increased to $2.10 (+90.91% YoY), showing strong earnings leverage in the quarter. Quality/mix: Gross margin declined to 64% (-5.74% YoY), consistent with cloud/infrastructure ramp costs and/or mix shift. This margin pressure aligns with Street concern that near-term buildout intensity may weigh on free cash flow and returns even if longer-term AI demand is strong.
Recent trend: Price targets have been cut materially by several firms following concerns about cloud growth pacing, sharply higher capex, and funding/leverage risks (e.g., Morgan Stanley to $213 from $320; Goldman to $220 from $320; JPMorgan to $230 from $270; UBS to $280 from $325; RBC to $195 from $250; Stifel to $275 from $350; Barclays to $310 from $330). This indicates broad de-risking of near-term expectations. Wall Street pros: Strong bull case remains centered on Oracle being a key AI/OCI beneficiary with multi-year demand and eventual large free cash flow (Guggenheim remains very bullish, calling it a “decade stock,” with a $400 PT). Wall Street cons: The dominant caution is execution and financing risk—capex ramp, uncertainty around funding needs, FCF pressure, potential tenant concentration, and doubts about hitting EPS targets on the Street’s prior timeline. Net take: Street is divided—long-term AI upside vs near-term balance-sheet/capex uncertainty—while the near-term trend in revisions is clearly negative.
